静脉对比剂暴露与需透析的脓毒症急性肾损伤未恢复的关联:一项全国性观察性研究
该回顾性观察研究利用日本诊断程序组合住院数据库(2011年1月至2016年12月),纳入入院2天内开始连续肾脏替代治疗并接受计算机断层扫描的脓毒症急性肾损伤患者。比较使用与未使用静脉对比剂的患者,经倾向性评分匹配后各3485对。匹配组间复合结局(院内死亡和出院时透析依赖)49.6% vs 50.2%(OR 0.98;95%CI 0.88, 1.07),院内死亡45.3% vs 46.1%(OR 0.97;95%CI 0.87, 1.06),透析依赖4.4% vs 4.1%(OR 1.08;95%CI 0.85, 1.31),肾脏替代治疗中位时间均为4[2-11]天(P=0.58),均无显著差异。结论提示静脉对比剂与脓毒症急性肾损伤透析患者的不良院内结局无关联,但需进一步研究评估普遍性。
要点
- 在需透析的脓毒症急性肾损伤患者中,静脉对比剂暴露组与未暴露组的复合结局(院内死亡和出院时透析依赖)分别为49.6%和50.2%,OR 0.98(95%CI 0.88, 1.07),无显著差异。
- 两组院内死亡率分别为45.3%和46.1%,OR 0.97(95%CI 0.87, 1.06),无显著差异。
- 两组出院时透析依赖率分别为4.4%和4.1%,OR 1.08(95%CI 0.85, 1.31),无显著差异。
- 两组肾脏替代治疗中位持续时间均为4[2-11]天,P=0.58,无显著差异。
- 该研究为回顾性观察性研究,作者结论认为静脉对比剂与脓毒症急性肾损伤透析患者的不良院内结局无关联,但需进一步研究评估普遍性。
适用人群与场景
- 脓毒症急性肾损伤患者,入院2天内开始连续肾脏替代治疗并接受计算机断层扫描者。
研究设计与关键结果
- 研究类型:回顾性观察性研究,使用日本诊断程序组合住院数据库,纳入2011年1月至2016年12月的数据。
- 样本量:静脉对比剂暴露组3782例,未暴露组6619例,经倾向性评分匹配后各3485对。
- 复合结局(院内死亡和出院时透析依赖):暴露组49.6% vs 未暴露组50.2%,OR 0.98(95%CI 0.88, 1.07),无显著差异。
- 院内死亡:暴露组45.3% vs 未暴露组46.1%,OR 0.97(95%CI 0.87, 1.06),无显著差异。
- 透析依赖:暴露组4.4% vs 未暴露组4.1%,OR 1.08(95%CI 0.85, 1.31),无显著差异。
- 肾脏替代治疗中位持续时间:暴露组4[2-11]天 vs 未暴露组4[2-11]天,P=0.58。
证据类型、等级与局限
- 证据类型:回顾性观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,该大型观察性研究不支持静脉对比剂与脓毒症急性肾损伤透析患者的不良院内结局存在关联。
- 作者指出,需进一步研究评估普遍性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: This study aimed to examine the association between the use of intravenous contrast and non-recovery from dialysis-requiring acute kidney injury (AKI-D) and in-hospital mortality among patients with sepsis.
METHODS: This was a retrospective observational study using the Japanese Diagnosis Procedure Combination inpatient database between January 2011 and December 2016. We identified patients with septic AKI who began continuous renal replacement therapy (RRT) within 2-days of admission and underwent computed tomography. We compared patients with AKI-D with and without the use of intravenous contrast for computed tomography and performed propensity score matching to adjust for confounders for the association between exposure to intravenous contrast and outcomes, including a composite outcome of in-hospital mortality and RRT dependence at discharge and RRT duration.
RESULTS: From 3782 and 6619 patients with septic AKI-D with and without intravenous contrast exposure, respectively, 3485 propensity score-matched pairs were generated. No significant differences were found in the outcomes between the propensity score-matched groups: a composite outcome of in-hospital mortality and RRT dependence, 49.6% vs. 50.2% (odds ratio (OR) 0.98; 95% CI (confidence interval) 0.88, 1.07); in-hospital mortality, 45.3% vs. 46.1% (OR 0.97; 95% CI 0.87, 1.06); RRT dependence, 4.4% vs 4.1% (OR 1.08; 95% CI 0.85, 1.31); and median (interquartile range) of RRT duration, 4 [2-11] days vs. 4 [2-11] days (P = 0.58).
CONCLUSIONS: This large observational study did not support an association between intravenous contrast media and adverse in-hospital outcomes in patients with septic AKI-D. Further studies are warranted to assess the generalizability.
参考来源
- Miyamoto Y, Iwagami M, Aso S, et al. Association between intravenous contrast media exposure and non-recovery from dialysis-requiring septic acute kidney injury: a nationwide observational study. Intensive Care Med. 2019. PMID: 31451861. doi:10.1007/s00134-019-05755-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。